Literature DB >> 8056575

Speech and swallowing function after oral and oropharyngeal resections: one-year follow-up.

B R Pauloski1, J A Logemann, A W Rademaker, F M McConnel, D Stein, Q Beery, J Johnson, M A Heiser, S Cardinale, D Shedd.   

Abstract

BACKGROUND: The purpose of this study was to determine whether the speech and swallowing function of surgically treated oral cancer patients improves between 1 month and 1 year after surgery.
METHODS: Speech and swallowing performances were assessed for 28 men and 10 women preoperatively and at 1, 3, 6, and 12 months postoperatively following a standardized protocol. Speech tasks included an audio recording of a brief conversation and of a standard articulation test; swallowing function was examined using videofluoroscopy. Data were also collected on the number and duration of speech/swallowing therapy sessions, as well as the amount and duration of radiotherapy.
RESULTS: Statistical analyses revealed that the speech and swallowing function of surgically treated oral and oropharyngeal cancer patients did not improve progressively between 1 and 12 months postsurgery; the level of functioning that these patients demonstrated at the 1- and 3-month posthealing evaluations was characteristic of their status at 1 year after surgery.
CONCLUSION: The lack of improvement between 1 and 12 months postsurgery may be related to the relatively small amount of therapy that these patients received during that period. Several outcome variables worsened significantly at the 6-month evaluation; the reversal of function at the 6-month evaluation point could be the effect of postoperative radiotherapy, because irradiated and nonirradiated patients differed in their pattern of recovery on oropharyngeal swallow efficiency and several speech variables.

Entities:  

Mesh:

Year:  1994        PMID: 8056575     DOI: 10.1002/hed.2880160404

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  25 in total

1.  Acupuncture for dysphagia after chemoradiation in head and neck cancer: rationale and design of a randomized, sham-controlled trial.

Authors:  Weidong Lu; Peter M Wayne; Roger B Davis; Julie E Buring; Hailun Li; Laura A Goguen; David S Rosenthal; Roy B Tishler; Marshall R Posner; Robert I Haddad
Journal:  Contemp Clin Trials       Date:  2012-03-02       Impact factor: 2.226

2.  Effects of reduced saliva production on swallowing in patients with Sjogren's syndrome.

Authors:  Nicole M Rogus-Pulia; Jeri A Logemann
Journal:  Dysphagia       Date:  2010-10-28       Impact factor: 3.438

3.  Change in tongue pressure in patients with head and neck cancer after surgical resection.

Authors:  Yoko Hasegawa; Kazuma Sugahara; Tatsuyuki Fukuoka; Shota Saito; Ayumi Sakuramoto; Nobuhide Horii; Saori Sano; Kana Hasegawa; Yuta Nakao; Tomoki Nanto; Kanenori Kadoi; Kuniyasu Moridera; Kazuma Noguchi; Kazuhisa Domen; Hiromitsu Kishimoto
Journal:  Odontology       Date:  2017-02-14       Impact factor: 2.634

Review 4.  Speech and swallowing after surgical treatment of advanced oral and oropharyngeal carcinoma: a systematic review of the literature.

Authors:  Anne Marijn Kreeft; Lisette van der Molen; Frans J Hilgers; Alfons J Balm
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11       Impact factor: 2.503

5.  Treatment of base of tongue cancer, stage III and stage IV with primary surgery: survival and functional outcomes.

Authors:  Khaled Al-Qahtani; Jen Rieger; Jeffery R Harris; Alex Mlynarek; David Williams; Tahera Islam; Hadi Seikaly
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-25       Impact factor: 2.503

6.  Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life.

Authors:  Christopher R Spencer; Hiram A Gay; Bruce H Haughey; Brian Nussenbaum; Douglas R Adkins; Tanya M Wildes; Todd A DeWees; James S Lewis; Wade L Thorstad
Journal:  Cancer       Date:  2014-08-20       Impact factor: 6.860

7.  Development of a new lingual range-of-motion assessment scale: normative data in surgically treated oral cancer patients.

Authors:  C L Lazarus; H Husaini; A S Jacobson; J K Mojica; D Buchbinder; D Okay; M L Urken
Journal:  Dysphagia       Date:  2014-05-09       Impact factor: 3.438

8.  Respiratory-swallow training in patients with head and neck cancer.

Authors:  Bonnie Martin-Harris; David McFarland; Elizabeth G Hill; Charlton B Strange; Kendrea L Focht; Zhuang Wan; Julie Blair; Katlyn McGrattan
Journal:  Arch Phys Med Rehabil       Date:  2014-12-11       Impact factor: 3.966

9.  Feeding Tube Utilization in Patients with Salivary Gland Malignancies.

Authors:  Diane Wenhua Chen; Jan S Lewin; Li Xu; Stephen Y Lai; G Brandon Gunn; Clifton David Fuller; Abdallah S R Mohamed; Aasheesh Kanwar; Erich M Sturgis; Katherine A Hutcheson
Journal:  Otolaryngol Head Neck Surg       Date:  2016-10-03       Impact factor: 3.497

10.  Short-term health-related quality of life and symptom control with docetaxel, cisplatin, 5-fluorouracil and cisplatin (TPF), 5-fluorouracil (PF) for induction in unresectable locoregionally advanced head and neck cancer patients (EORTC 24971/TAX 323).

Authors:  C M L van Herpen; M E Mauer; R Mesia; M Degardin; S Jelic; C Coens; J Betka; J Bernier; E Remenar; J S Stewart; J H Preiss; D van den Weyngaert; A Bottomley; J B Vermorken
Journal:  Br J Cancer       Date:  2010-09-14       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.